Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
Archivio istituzionale della ricerca dell'Università degli Studi di Palermo
Objective. Ovarian cancer comprises several histological groups with widely differing levels of survival. We
aimed to explore international variation in survival for each group to help interpret international differences in
survival from all ovarian cancers combined. We also examined differences in stage-specific survival.
Methods. The CONCORD programme is the largest population-based study of global trends in cancer survival,
including data from 60 countries for 695,932 women (aged 15–99 years) diagnosed with ovarian cancer during
1995–2009. We defined six histological groups: type I epithelial, type II epithelial, germ cell, sex cord-stromal,
other specific non-epithelial and non-specific morphology, and estimated age-standardised 5-year net survival
for each country by histological group. We also analysed data from67 cancer registries for 233,659 women diagnosed
from 2001 to 2009, for whom information on stage at diagnosis was available. We estimated agestandardised
5-year net survival by stage at diagnosis (localised or advanced).
Results. Survival fromtype I epithelial ovarian tumours for women diagnosed during 2005–09 ranged from40
to 70%. Survival from type II epithelial tumours was much lower (20–45%). Survival fromgermcell tumours was
higher than that of type II epithelial tumours, but also varied widely between countries. Survival for sex-cord
stromal tumours was higher than for the five other groups. Survival from localised tumours was much higher
than for advanced disease (80% vs. 30%).
Conclusions. There is wide variation in survival between histological groups, and stage at diagnosis remains an
important factor in ovarian cancer survival. International comparisons of ovarian cancer survival should incorporate
histology.
Matz, M., Coleman, M., Carreira, H., Salmerã³n, D., Chirlaque, M., Allemani, C., et al. (2017). Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404]. GYNECOLOGIC ONCOLOGY [10.1016/j.ygyno.2017.06.033].
Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404]
Objective. Ovarian cancer comprises several histological groups with widely differing levels of survival. We
aimed to explore international variation in survival for each group to help interpret international differences in
survival from all ovarian cancers combined. We also examined differences in stage-specific survival.
Methods. The CONCORD programme is the largest population-based study of global trends in cancer survival,
including data from 60 countries for 695,932 women (aged 15–99 years) diagnosed with ovarian cancer during
1995–2009. We defined six histological groups: type I epithelial, type II epithelial, germ cell, sex cord-stromal,
other specific non-epithelial and non-specific morphology, and estimated age-standardised 5-year net survival
for each country by histological group. We also analysed data from67 cancer registries for 233,659 women diagnosed
from 2001 to 2009, for whom information on stage at diagnosis was available. We estimated agestandardised
5-year net survival by stage at diagnosis (localised or advanced).
Results. Survival fromtype I epithelial ovarian tumours for women diagnosed during 2005–09 ranged from40
to 70%. Survival from type II epithelial tumours was much lower (20–45%). Survival fromgermcell tumours was
higher than that of type II epithelial tumours, but also varied widely between countries. Survival for sex-cord
stromal tumours was higher than for the five other groups. Survival from localised tumours was much higher
than for advanced disease (80% vs. 30%).
Conclusions. There is wide variation in survival between histological groups, and stage at diagnosis remains an
important factor in ovarian cancer survival. International comparisons of ovarian cancer survival should incorporate
histology.
Matz, M., Coleman, M., Carreira, H., Salmerã³n, D., Chirlaque, M., Allemani, C., et al. (2017). Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404]. GYNECOLOGIC ONCOLOGY [10.1016/j.ygyno.2017.06.033].
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/246035
Citazioni
1
2
3
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.